Impact of ABL kinase domain mutations on the outcome of patients with chronic myeloid leukemia (CML).
Kendra Lynn Sweet
No relevant relationships to disclose
Rami S. Komrokji
No relevant relationships to disclose
Najla Al Ali
No relevant relationships to disclose
Robert M. Crescentini
No relevant relationships to disclose
Gelenis Domingo
No relevant relationships to disclose
Julio C. Chavez
No relevant relationships to disclose
Samir Dalia
No relevant relationships to disclose
Sara Tinsley
No relevant relationships to disclose
Jeffery Lancet
No relevant relationships to disclose
Ling Zhang
No relevant relationships to disclose
Javier Pinilla-Ibarz
No relevant relationships to disclose